BioXcel Therapeutics Inc (BTAI) Stock: A SWOT Analysis

1d ago, source: newsheater

Steinhart Richard I, the Chief Financial Officer of BioXcel Therapeutics Inc, sale 1,069 shares at $2.63 during a trade that took place back on Apr 04 ’24, which means that Steinhart Richard I is ...

BioXcel Therapeutics Inc (BTAI) Shares Up Despite Recent Market Volatility

6mon ago, source: newsheater

Reports are indicating that there were more than several insider trading activities at BTAI starting from Mehta Vimal, who sale 5,268 shares at the price of $2.62 back on Apr 04 ’24. After this action ...

Buy Rating Reaffirmed for Repare Therapeutics on Strong Clinical Outlook and Attractive Valuation

4d ago, source:

Analyst David Martin PhD of Bloom Burton maintained a Buy rating on Repare Therapeutics (RPTX – Research Report), retaining the price ...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), Danaher (DHR) and Roche Holding AG (OtherRHHVF)

1d ago, source:

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Fate Therapeutics (FATE – Research Report), ...